Sign in

CIK 0001479419

  • Non-accelerated filer
  • Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
270604595
Phone
+1 781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-07-20 CDK ASSOCIATES, L.L.C. 10% owner Purchase +215,000 $15.00 $3.2M 215,000
2017-07-19 Iwicki Mark T Chief Executive Officer Grant or award · Stock Option (right to buy) +78,632 78,632
2017-07-19 Brazzell Romulus K Chief Medical Officer Grant or award · Stock Option (right to buy) +47,142 47,142
2017-07-19 Chen Hongming Chief Scientific Officer Grant or award · Stock Option (right to buy) +28,800 28,800
2017-07-19 LANGER ROBERT Director Grant or award · Stock Option (right to buy) +12,960 12,960
2017-07-19 TEPPER ROBERT I Director Grant or award · Stock Option (right to buy) +12,960 12,960
2017-07-19 Rosen Howard B Director Grant or award · Stock Option (right to buy) +12,960 12,960
2017-07-19 Hill Paulina Director Grant or award · Stock Option (right to buy) +12,960 12,960
2017-07-19 Paull Robert Bradley Director Grant or award · Stock Option (right to buy) +12,960 12,960
2017-07-19 Grunberg Gregory Director Grant or award · Stock Option (right to buy) +12,960 12,960
2017-07-19 Shah Rajeev M. Director Grant or award · Stock Option (right to buy) +12,960 12,960
2017-07-19 Reumuth Mary Chief Financial Officer Grant or award · Stock Option (right to buy) +28,973 28,973

Page 24 of 24 · 472 trades